Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Rationale and Design of the Phase 3 KEYLYNK-013 Study of Pembrolizumab With Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Limited-Stage Small-Cell Lung Cancer.
Journal: Clinical lung cancer
Published: March 08, 2022
Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: September 29, 2018
Showing 1-2 of 2
Last Updated: 09/26/2026